Characteristic | Number of Patients (%) (n=42) | |
---|---|---|
Gender | Â | |
 | Female | 23 (55%) |
 | Male | 19 (45%) |
Age (Years) | Â | |
 | Median (range) | 60 (27–85) |
Ethnicity | Â | |
 | Caucasian | 34 (81%) |
 | Other | 8 (19%) |
ECOG performance status | Â | |
 | Median (range) | 1 (0–1) |
Tumour type | Â | |
 | NSCLC | 10 (24%) |
 | Gastrointestinal | 7 (17%) |
 | Genitourinary | 4 (10%) |
 | Prostate | 4 (10%) |
 | Head and neck | 3 (7%) |
 | Melanoma | 3 (7%) |
 | Sarcoma | 3 (7%) |
 | Other | 8 (19%) |
Number of prior chemotherapy regimens | Â | |
 | Median (range) | 1 (0–3) |